{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:31:08Z","timestamp":1790818268418,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1245\/aso.2003.03.005","type":"journal-article","created":{"date-parts":[[2003,11,3]],"date-time":"2003-11-03T22:24:24Z","timestamp":1067898264000},"page":"1100-1105","source":"Crossref","is-referenced-by-count":43,"title":["Pitfalls of Positive Findings in Staging Esophageal Cancer With F-18-Fluorodeoxyglucose Positron Emission Tomography"],"prefix":"10.1245","volume":"10","author":[{"given":"Henderik L.","family":"van Westreenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre A. M.","family":"Heeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter L.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik M.","family":"van Dullemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Th. M.","family":"Plukker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"471","volume":"10","author":"TW Rice","year":"2000","unstructured":"Rice TW. Clinical staging of esophageal carcinoma: CT, EUS, and PET. Chest Surg Clin N Am 2000;10:471?85.","journal-title":"Chest Surg Clin N Am"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0003-4975(97)00619-X","volume":"64","author":"MI Block","year":"1997","unstructured":"Block MI, Patterson GA, Sundaresan RS, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770?6.","journal-title":"Ann Thorac Surg"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2000.18.18.3202","volume":"18","author":"P Flamen","year":"2000","unstructured":"Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202?10.","journal-title":"J Clin Oncol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2214\/ajr.168.2.9016218","volume":"168","author":"FL Flanagan","year":"1997","unstructured":"Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 1997;168:417?24.","journal-title":"Am J Roentgenol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bjc.1998.526","volume":"78","author":"AC Kole","year":"1998","unstructured":"Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 1998;78:521?7.","journal-title":"Br J Cancer"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0003-4975(97)00624-3","volume":"64","author":"JD Luketich","year":"1997","unstructured":"Luketich JD, Schauer PR, Meltzer CC, et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997;64:765?9.","journal-title":"Ann Thorac Surg"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00003072-200011000-00005","volume":"25","author":"CC Meltzer","year":"2000","unstructured":"Meltzer CC, Luketich JD, Friedman D, et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 2000;25:882?7.","journal-title":"Clin Nucl Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0003-4975(02)03875-4","volume":"74","author":"MB Wallace","year":"2002","unstructured":"Wallace MB, Nietert PJ, Earle C, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy\/laparoscopy. Ann Thorac Surg 2002;74:1026?32.","journal-title":"Ann Thorac Surg"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archsurg.137.9.1001","volume":"137","author":"SM Wren","year":"2002","unstructured":"Wren SM, Stijns P, Srinivas S. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 2002;137:1001?7.","journal-title":"Arch Surg"},{"key":"CR10","first-page":"808","volume":"41","author":"JY Choi","year":"2000","unstructured":"Choi JY, Lee KH, Shim YM, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 2000;41:808?15.","journal-title":"J Nucl Med"},{"key":"CR11","first-page":"1412","volume":"42","author":"H Zhuang","year":"2001","unstructured":"Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412?7.","journal-title":"J Nucl Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1095-0397(01)00060-7","volume":"4","author":"PS Duarte","year":"2003","unstructured":"Duarte PS, Zhuang H, Castellucci P, Alavi A. The receiver operating characteristic curve for the standard uptake value in a group of patients with bone marrow metastasis. Mol Imag Biol 2003;4:157?60.","journal-title":"Mol Imag Biol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1095-0397(99)00006-0","volume":"2","author":"AT Nguyen","year":"2003","unstructured":"Nguyen AT, Akhurst T, Larson SM, Coit DG, Brady MS. PET Scanning with 18F 2-Fluoro-2-Deoxy-D-glucose (FDG) in patients with melanoma: benefits and limitations. Clin Pos Imag 2003;2:93?8.","journal-title":"Clin Pos Imag"},{"key":"CR14","first-page":"235","volume":"27","author":"K Hamacher","year":"1986","unstructured":"Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2- deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235?8.","journal-title":"J Nucl Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiographics.19.1.g99ja0761","volume":"19","author":"PD Shreve","year":"1999","unstructured":"Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61?77.","journal-title":"Radiographics"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/cncr.10330","volume":"94","author":"H Kato","year":"2002","unstructured":"Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002;94:921?8.","journal-title":"Cancer"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0003-4975(00)02221-9","volume":"71","author":"K Kim","year":"2001","unstructured":"Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 2001;71:290?4.","journal-title":"Ann Thorac Surg"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.med.53.082901.104028","volume":"53","author":"J Czernin","year":"2002","unstructured":"Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med 2002;53:89?112.","journal-title":"Annu Rev Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1067\/msy.2000.109967","volume":"128","author":"JE Phay","year":"2000","unstructured":"Phay JE, Hussain HB, Moley JF. Strategy for identification of novel glucose transporter family members by using internet-based genomic databases. Surgery 2000;128:946?51.","journal-title":"Surgery"},{"key":"CR20","first-page":"658","volume":"43","author":"T Ishimori","year":"2002","unstructured":"Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A?mediated lymphocyte activation. J Nucl Med 2002;43:658?63.","journal-title":"J Nucl Med"},{"key":"CR21","first-page":"1972","volume":"33","author":"R Kubota","year":"1992","unstructured":"Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972?80.","journal-title":"J Nucl Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/BF01367602","volume":"23","author":"LG Strauss","year":"1996","unstructured":"Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409?15.","journal-title":"Eur J Nucl Med"},{"key":"CR23","first-page":"1301","volume":"36","author":"S Yamada","year":"1995","unstructured":"Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine- induced inflammatory tissue. J Nucl Med 1995;36:1301?6.","journal-title":"J Nucl Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-4295(99)00272-1","volume":"54","author":"U Cremerius","year":"1999","unstructured":"Cremerius U, Wildberger JE, Borchers H, et al. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? Results in a study of 50 patients. Urology 1999;54:900?4.","journal-title":"Urology"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2003.03.005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/ASO.2003.03.005\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2003.03.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T04:51:18Z","timestamp":1559623878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/ASO.2003.03.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1245\/aso.2003.03.005","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}